Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $245.38, with a market capitalization of 33.58B. The stock trades at a price-to-earnings (P/E) ratio of -102.81.
On 2026-01-21, Natera(NTRA) stock traded between a low of $234.04 and a high of $255.38. Shares are currently priced at $245.38, which is +4.8% above the low and -3.9% below the high.
Natera(NTRA) shares are trading with a volume of 1.42M, against a daily average of 1.35M.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
NTRA News
Natera (NTRA) announced the publication in npj Precision Oncology of the validation study for its Latitude tissue-free molecular residual disease assay, or tfMR...
Natera (NTRA) is back in focus after issuing guidance that points to a 39% year over year jump in Q4 revenue, projected 35% full year 2025 revenue growth, and f...
Investors in Natera Inc (Symbol: NTRA) saw new options begin trading this week, for the March 20th expiration. At Stock Options Channel , our YieldBoost formula...
Analyst ratings
87%
of 23 ratingsMore NTRA News
Natera has recently reported strong 2025 revenue growth, unveiled an AI-driven, multi-modal upgrade to its Signatera MRD test, and expanded its fetal genetic te...
If you are wondering whether Natera's current share price lines up with its underlying value, you are not alone. This article is built to help you connect the d...